Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease

This study has been completed.
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
Tehran University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT00664599
First received: April 20, 2008
Last updated: April 27, 2008
Last verified: April 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2008
  Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)